Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2019-06-28 AGM Information
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
PHR_Wykaz akcjonariuszy posiad. pow. 5% głosów na ZWZ w dniu 25 06 2019
AGM Information Classification · 99% confidence The document is titled 'Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym Zgromadzeniu Pharmena S.A. w dniu 25.06.2019 r.', which translates to 'List of shareholders holding at least 5% of the votes at the Annual General Meeting of Pharmena S.A. on 25.06.2019'. This content explicitly details the voting results and shareholder structure related to a General Meeting (ZWZ/AGM). This aligns directly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting. The document is short and contains the final results, not an announcement of a future report.
2019-06-28 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ w dniu 25.06.2019 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text is very short (383 characters) and explicitly states that the Management Board of PHARMENA S.A. is attaching a list of shareholders holding at least 5% of the votes from the Annual General Meeting (Zwyczajnym Walnym Zgromadzeniu) held on 25.06.2019. This content—a specific announcement regarding voting results or shareholder structure following a general meeting—fits best under Declaration of Voting Results & Voting Rights Announcements (DVA). Although it mentions the AGM, the core content is the declaration of voting power distribution among major shareholders post-meeting, not the AGM presentation itself (AGM-R) or a general proxy solicitation (PSI). Given the specific nature of reporting voting power distribution post-meeting, DVA is the most precise fit.
2019-06-28 Polish
PHR_Notka biograficzna_czlonek RN_Z.Molenda
Board/Management Information Classification · 98% confidence The document text is in Polish and details information about a member of the Supervisory Board ('Rada Nadzorcza') of Pharmena S.A., including their appointment date, name (Zbigniew Molenda), function, professional background, and other roles held in related or unrelated companies. This content directly relates to the composition and governance structure of the company's board. This aligns perfectly with the definition of Board/Management Information (MANG), which covers announcements of changes or details regarding the board of directors or senior management.
2019-06-26 Polish
PHR_Notka biograficzna_czlonek RN_J.Szwajcowski
Board/Management Information Classification · 98% confidence The document text is in Polish and details information about a member of the Supervisory Board ('Członek Rady Nadzorczej') named Jacek Szwajcowski, including his appointment date, background, education, and other roles held. This content directly relates to the composition and background of the company's governing body (Board of Directors/Supervisory Board). This aligns perfectly with the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2019-06-26 Polish
PHR_Notka biograficzna_czlonek RN_J.Gębicki
Board/Management Information Classification · 98% confidence The document text is in Polish and contains structured information about a member of the Supervisory Board ('Rada Nadzorcza') of a company (Pharmena S.A.). It details their appointment date, name, function, education, professional history, and other relevant activities, including potential conflicts of interest. This content directly relates to the composition and structure of the company's oversight body. This aligns perfectly with the definition of Board/Management Information (MANG), which covers announcements of changes or details regarding the board of directors or senior management.
2019-06-26 Polish
PHR_Notka biograficzna_czlonek RN_J.Dauenhauer
Board/Management Information Classification · 98% confidence The document text is in Polish and details information about a member of the Supervisory Board ('Rada Nadzorcza') named Jacek Dauenhauer, including his appointment date, education, professional history, and other roles held in related or affiliated companies. This content directly relates to the composition and changes within the company's governing body (Board of Directors/Supervisory Board). This aligns perfectly with the definition of Board/Management Information (MANG).
2019-06-26 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.